TrialJournal of virology2011

An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Frank O Pettersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.